IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Pakistani man arrested for alleged ISIS terror plot targeting Jewish people in New York City

    00:56
  • Georgia teen and father appear in court on school shooting charges

    02:33
  • Georgia official tours state to assure voting is fair

    02:59
  • Boeing's troubled Starliner heads home without its crew

    01:37
  • Former Vice President Dick Cheney says he will vote for Harris

    01:45
  • Judge delays Trump sentencing in hush money case

    03:08
  • American woman killed in West Bank protest

    01:34
  • Biden administration launches probe into airline reward programs

    01:29
  • NFL coach makes it a family affair by hiring his dad as an assistant coach

    01:33
  • Hunter Biden pleads guilty to federal tax charges

    01:57
  • Teen suspect charged with four counts of murder in Georgia school shooting

    02:29
  • Georgia school shooting highlights debate over cell phones in schools

    01:39
  • Use of button alert system played role in school shooting response

    01:29
  • Trump says he would appoint Elon Musk to head government efficiency commission

    01:40
  • U.S. Steel caught in middle of dispute over sale to Japanese company

    01:59
  • Fewer Black students enter some top colleges after court's affirmative action ruling

    03:03
  • 4 killed, 9 injured in Georgia high school shooting

    02:48
  • Netanyahu defiant amid stalled cease-fire talks

    02:26
  • Harris makes economic pitch and accepts debate rules

    01:53
  • Young voters support Harris in greater numbers but are concerned about inflation

    02:34

NBC News Exclusive: Ozempic and Wegovy Novo Nordisk CEO speaks out on high prices, drug shortages

04:20

Blockbuster drugs Ozempic and Wegovy have sparked conversation and changed weight loss worldwide. In an exclusive interview, NBC News’ Megan Fitzgerald sits down with Novo Nordisk CEO Lars Fruergaard Jørgensen who helmed it all, and presses him on the high price, drug shortages, and long-term effects.